Patents Assigned to DHARMA BIOMEDICAL, LLC
  • Patent number: 10568925
    Abstract: The invention concerns carbon dioxide extracts of Curcuma amada (mango ginger), including supercritical carbon dioxide extracts of C. amada; methods for their production; compositions comprising the extracts; methods for treating or delaying the onset of conditions such as cell proliferation disorder (e.g., cancer), inflammation, infection, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hyperglycemia, platelet hyper-aggregation, immune disorder such as autoimmune disorder, or neurodegenerative condition; and methods for inhibiting expression of Bcl-2, Bak, and p53 genes; inhibiting expression of the COX-2 and NF-kB genes, inhibiting production of phosphorylated target of rapamycin (TOR), modulating AMP-activated protein kinase (AMPK), inhibiting protein kinase B (AKT) signaling, modulating the Ras/Raf/MEK/ERK signaling pathway, and modulating the Ras/PI3K/PTEN/Akt/mTOR signaling pathway.
    Type: Grant
    Filed: January 31, 2016
    Date of Patent: February 25, 2020
    Assignees: DHARMA BIOMEDICAL, LLC, FLAVEX NATUREXTRAKTE GMBH
    Inventors: Steven J. Melnick, Karl-Werner Quirin, Cheppail Ramachandran, Melvin Rothberg
  • Patent number: 9913870
    Abstract: The subject invention pertains to supercritical carbon dioxide extracts of Commiphora mukul resin (guggul), which can be modified or not modified by some ethanol addition; methods for their production; and methods of use, such as inhibiting HMG-CoA reductase, inhibiting transformation of pre-adipocytes to adipocytes, inhibiting triglyceride storage, promoting insulin sensitivity in adipocytes, treatment of disorders (for example, hypercholesterolemia, hyperlipidemia, hyperglycemia, obesity, metabolic syndrome, cardiovascular disease, atherosclerotic heart disease, autoimmune disorder, insulin resistance, leptin resistance, arthritis, cell proliferation disorder, such as cancer and atherosclerosis; damaged skin, sores, cuts, rashes, bruises, dryness, burns, sunburn, radiation burn, and infection), and regulating or suppressing appetite.
    Type: Grant
    Filed: January 11, 2013
    Date of Patent: March 13, 2018
    Assignees: DHARMA BIOMEDICAL, LLC, FLAVEX NATUREXTRAKTE GMBH
    Inventors: Steven J. Melnick, Karl-Werner Quirin, Cheppail Ramachandran, Melvin Rothberg
  • Publication number: 20150010615
    Abstract: The subject invention pertains to supercritical carbon dioxide extracts of Commiphora mukul resin (guggul), which can be modified or not modified by some ethanol addition; methods for their production; and methods of use, such as inhibiting HMG-CoA reductase, inhibiting transformation of pre-adipocytes to adipocytes, inhibiting triglyceride storage, promoting insulin sensitivity in adipocytes, treatment of disorders (for example, hypercholesterolemia, hyperlipidemia, hyperglycemia, obesity, metabolic syndrome, cardiovascular disease, atherosclerotic heart disease, autoimmune disorder, insulin resistance, leptin resistance, arthritis, cell proliferation disorder, such as cancer and atherosclerosis; damaged skin, sores, cuts, rashes, bruises, dryness, burns, sunburn, radiation burn, and infection), and regulating or suppressing appetite.
    Type: Application
    Filed: January 11, 2013
    Publication date: January 8, 2015
    Applicants: DHARMA BIOMEDICAL, LLC, FLAVEX NATUREXTRAKTE GMBH
    Inventors: Steven J. Melnick, Karl-Werner Quirin, Cheppail Ramachandran, Melvin Rothberg